KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zoetis (ZTS) Receivables (2016 - 2025)

Zoetis (ZTS) has disclosed Receivables for 13 consecutive years, with $1.5 billion as the latest value for Q3 2025.

  • On a quarterly basis, Receivables rose 9.21% to $1.5 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 billion, a 9.21% increase, with the full-year FY2024 number at $1.4 billion, up 2.42% from a year prior.
  • Receivables was $1.5 billion for Q3 2025 at Zoetis, roughly flat from $1.5 billion in the prior quarter.
  • In the past five years, Receivables ranged from a high of $1.5 billion in Q3 2025 to a low of $1.1 billion in Q1 2021.
  • A 5-year average of $1.3 billion and a median of $1.3 billion in 2022 define the central range for Receivables.
  • Peak YoY movement for Receivables: grew 18.9% in 2021, then dropped 2.95% in 2023.
  • Zoetis' Receivables stood at $1.2 billion in 2021, then grew by 8.98% to $1.3 billion in 2022, then increased by 5.91% to $1.4 billion in 2023, then grew by 2.42% to $1.4 billion in 2024, then rose by 10.47% to $1.5 billion in 2025.
  • Per Business Quant, the three most recent readings for ZTS's Receivables are $1.5 billion (Q3 2025), $1.5 billion (Q2 2025), and $1.4 billion (Q1 2025).